Spok Holdings Inc (SPOK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Spok Holdings Inc (SPOK) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.44 Million) by net assets ($140.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Spok Holdings Inc market capitalisation for the company's overall valuation and market capitalisation.
Spok Holdings Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Spok Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Spok Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Spok Holdings Inc ranked by their cash flow conversion efficiency. Explore Spok Holdings Inc cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Horizon Securities Co Ltd
TWO:6015
|
0.004x |
|
Afrimat
JSE:AFT
|
0.117x |
|
PT Estee Gold Feet Tbk
JK:EURO
|
-0.067x |
|
Bank of Zhengzhou Co. Ltd
F:3BZ
|
-0.076x |
|
Froch Enterprise Co Ltd
TW:2030
|
-0.032x |
|
Utah Medical Products Inc
NASDAQ:UTMD
|
0.026x |
|
Yesco Holdings Co. Ltd
KO:015360
|
0.182x |
|
Power Nickel Inc
V:PNPN
|
-0.844x |
Annual Cash Flow Conversion Efficiency for Spok Holdings Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of Spok Holdings Inc from 2000 to 2025. View current stock price of Spok Holdings Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $146.38 Million | $28.95 Million | 0.198x | +5.81% |
| 2024-12-31 | $154.75 Million | $28.92 Million | 0.187x | +16.90% |
| 2023-12-31 | $163.77 Million | $26.18 Million | 0.160x | +326.15% |
| 2022-12-31 | $172.08 Million | $6.46 Million | 0.038x | -18.22% |
| 2021-12-31 | $173.69 Million | $7.97 Million | 0.046x | -64.82% |
| 2020-12-31 | $200.61 Million | $26.16 Million | 0.130x | +178.94% |
| 2019-12-31 | $250.09 Million | $11.69 Million | 0.047x | +24.45% |
| 2018-12-31 | $274.55 Million | $10.31 Million | 0.038x | -29.83% |
| 2017-12-31 | $290.53 Million | $15.56 Million | 0.054x | -53.96% |
| 2016-12-31 | $322.09 Million | $37.46 Million | 0.116x | +2.06% |
| 2015-12-31 | $333.55 Million | $38.01 Million | 0.114x | -23.48% |
| 2014-12-31 | $279.06 Million | $41.56 Million | 0.149x | -20.32% |
| 2013-12-31 | $269.95 Million | $50.46 Million | 0.187x | -35.52% |
| 2012-12-31 | $251.42 Million | $72.88 Million | 0.290x | -11.24% |
| 2011-12-31 | $252.44 Million | $82.44 Million | 0.327x | -26.04% |
| 2010-12-31 | $184.39 Million | $81.42 Million | 0.442x | -31.16% |
| 2009-12-31 | $158.80 Million | $101.86 Million | 0.641x | -14.87% |
| 2008-12-31 | $140.74 Million | $106.04 Million | 0.753x | +146.29% |
| 2007-12-31 | $373.57 Million | $114.28 Million | 0.306x | -1.11% |
| 2006-12-31 | $475.97 Million | $147.24 Million | 0.309x | +18.40% |
| 2005-12-31 | $532.99 Million | $139.25 Million | 0.261x | +33.38% |
| 2004-12-31 | $583.34 Million | $114.27 Million | 0.196x | -64.74% |
| 2003-12-31 | $326.26 Million | $181.25 Million | 0.556x | -69.30% |
| 2002-12-31 | $114.22 Million | $206.66 Million | 1.809x | +6428.13% |
| 2001-12-31 | $-1.66 Billion | $47.37 Million | -0.029x | +91.66% |
| 2000-12-31 | $-94.26 Million | $32.33 Million | -0.343x | -- |
About Spok Holdings Inc
Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance. The company delivers clinical information to care teams when and where it matters to enhance patient outcomes; and pro… Read more